Poor outcomes of proliferative glomerulonephritis with monoclonal IgG deposits in renal allografts: a retrospective multicenter study
Authors:
- 22 July 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 36 (1) , 93-101
Abstract
Background Proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) in renal allografts is a rare, renal-limited disease. No study has reported the long-term outcomes and prognostic features of PGNMID in renal allografts in the Chinese population. Methods We retrospectively included transplant patients diagnosed with PGNMID who underwent renal allograft biopsy at three transplant centers from April 2012 to July 2020. We observed the clinicopathologic features, explored the long-term graft survival, and investigated the characteristics associated with the prognosis. Results A total of 13 transplant patients with PGNMID were included, out of 3821 biopsies. The mean follow-up time was 55 months since kidney transplantation (KTx). At diagnosis, all patients presented with proteinuria (100%) and most of them with hematuria (92%). IgG3κ (69%) was the main immunofluorescence (IF) subtype. The median graft survival of the total cohort was 17 months from diagnosis and 49 months from kidney transplantation. During follow-up, 9 patients needed dialysis and 2 out of 9 patients who progressed to dialysis died of infection. Primary membranoproliferative glomerulonephritis (MPGN) (P = 0.014) and MPGN pattern at diagnostic biopsy (P < 0.001) were associated with a higher risk of graft loss. Conclusions The long-term outcome of allograft PGNMID was relatively poor in the Chinese population. Primary MPGN and MPGN pattern in renal allograft were associated with poor outcomes. Graphical abstractKeywords
Funding Information
- National Natural Science Foundation of China (81570681)
- BWS20J001
- National Natural Science Foundation of China (81570681)
- BWS20J001
This publication has 18 references indexed in Scilit:
- Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograftKidney International, 2018
- Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case reportBMC Nephrology, 2017
- Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantationKidney International, 2017
- De novo proliferative glomerulonephritis with monoclonal IgG deposits of the IgG1κ subtype in a kidney allograftNephrology, 2016
- Proliferative glomerulonephritis with monoclonal immunoglobulin in renal allograftsClinical Kidney Journal, 2015
- Proliferative glomerulonephritis with monoclonal immunoglobulin deposition disease: The utility of routine staining with immunoglobulin light chainsIndian Journal of Nephrology, 2015
- Proliferative Glomerulonephritis With Monoclonal IgG Deposits Recurs or May Develop De Novo in Kidney AllograftsAmerican Journal of Kidney Diseases, 2011
- Proliferative Glomerulonephritis with Monoclonal IgG Deposits Recurs in the AllograftClinical Journal of the American Society of Nephrology, 2011
- Proliferative Glomerulonephritis with Monoclonal IgG DepositsJournal of the American Society of Nephrology, 2009
- Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune-complex glomerulonephritisKidney International, 2004